(Q47784739)

5 February 2018

title

Expression of the thrombospondin 1 fragment 167-569 in C6 glioma cells stimulates tumorigenicity despite reduced neovascularization (English)

1 reference

5 February 2018

1 reference

Florence de Fraipont

1 reference

5 February 2018

Michelle Keramidas

1 reference

5 February 2018

Michelle El Atifi

1 reference

5 February 2018

Edmond M Chambaz

1 reference

5 February 2018

François Berger

1 reference

5 February 2018

Jean-Jacques Feige

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

5 February 2018

published in

Oncogene

1 reference

5 February 2018

volume

1 reference

5 February 2018

issue

1 reference

5 February 2018

page(s)

3642-3649

1 reference

5 February 2018

Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Analysis of small latent transforming growth factor-beta complex formation and dissociation by surface plasmon resonance. Absence of direct interaction with thrombospondins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Integrin-associated protein and thrombospondin-1 as endothelial mechanosensitive death mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Models for assessment of angiogenesis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

The role of transforming growth factor beta in glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

21 January 2018

Brain tumors. Part 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Brain tumors. Part 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Angiogenesis in malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Inhibition of angiogenesis by thrombospondin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207438

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207438

1 reference

5 February 2018

1 reference

5 February 2018